Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review.

Thus, given the gaps in our knowledge, recommendations for treatment of this common and important co-morbidity are preliminary. Accordingly, the conduct of larger, randomized controlled trials for this co-morbidity is clearly needed.